| Stem definition | Drug id | CAS RN |
|---|---|---|
| gabamimetic agents | 2278 | 62666-20-0 |
None
| Property | Value | Reference |
|---|---|---|
| BA (Bioavailability) | 60 % | Kim MT, Sedykh A, Chakravarti SK, Saiakhov RD, Zhu H |
| Date | Agency | Company | Orphan |
|---|---|---|---|
| Jan. 1, 1985 | YEAR INTRODUCED |
None
None
None
None
| Source | Code | Description |
|---|---|---|
| ATC | N03AG05 | NERVOUS SYSTEM ANTIEPILEPTICS ANTIEPILEPTICS Fatty acid derivatives |
| MeSH PA | D018726 | Anti-Dyskinesia Agents |
| MeSH PA | D000927 | Anticonvulsants |
| MeSH PA | D000928 | Antidepressive Agents |
| MeSH PA | D000978 | Antiparkinson Agents |
| MeSH PA | D002491 | Central Nervous System Agents |
| MeSH PA | D018682 | GABA Agents |
| MeSH PA | D018755 | GABA Agonists |
| MeSH PA | D018377 | Neurotransmitter Agents |
| MeSH PA | D011619 | Psychotropic Drugs |
None
None
None
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 12.28 | acidic |
| pKa2 | 13.0 | acidic |
| pKa3 | 3.38 | Basic |
None
None
| Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
|---|---|---|---|---|---|---|---|---|---|
| GABA-A receptor alpha-1/beta-2/gamma-2 | Ion channel | Ki | 4.40 | WOMBAT-PK | |||||
| GABA-A receptor; anion channel | Ion channel | Ki | 4.40 | CHEMBL | |||||
| GABA-A receptor; anion channel | Ion channel | Ki | 4.85 | CHEMBL |
| ID | Source |
|---|---|
| D05621 | KEGG_DRUG |
| C0072076 | UMLSCUI |
| CHEBI:135422 | CHEBI |
| CHEMBL287631 | ChEMBL_ID |
| DB00837 | DRUGBANK_ID |
| C017985 | MESH_SUPPLEMENTAL_RECORD_UI |
| 44115 | PUBCHEM_CID |
| 4656 | INN_ID |
| 38C836J57Z | UNII |
| 34568 | RXNORM |
| 005334 | NDDF |
None